: Friday, January 17, 2020
Korea‘s Bio Industry
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
[Column] Navigating a changing healthcare landscape with focus on patient centricity
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
Each year, November 14 i...
[Column] Digital healthcare for efficient distribution of medical resources
The Ministry of Health a...
[Reporter’s Notebook] SillaJen should be ashamed of itself
It was an obvious failur...
[Column] Drug regulator needs adequate expertise to promote medical devices
In the healthcare sector...
Korea Biomedical Review
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’
“Is there any trouble be...
[Reporter’s Notebook] Roche agreed, MSD and BMS should, too
Immunotherapies have bec...
[Reporter’s Notebook]MFDS incapable of reviewing new drugs?
The most shocking news i...
[Column] Measles and fake news
Health authorities are having a rough time u...
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors
Adolescent Protection Policy
E-mail address privacy
The Korean Doctors’ Weekly Co., Ltd.
76-1, Dongmak-ro, Mapo-gu, Seoul, Korea
Email : email@example.com
Title : Korea Biomedical Review
Online newspaper registration number : Seoul 아 04285
Date of registration : December 19, 2016
Publishing date : February 22, 2017
Publisher-Editor : Yang Kyung-cheol
Chief Executive Officer : Yang Kyung-cheol
Executive Editor : Choi Sung-jin
pyright © 2020 KBR. All rights reserved.
Back to Top